Buy Retatrutide 20mg UK | GLP-1 Research Peptide
Buy Retatrutide 20mg UK | GLP-1 Research Peptide
Buy Retatrutide 20mg UK | GLP-1 Research Peptide
Buy Retatrutide 20mg UK | GLP-1 Research Peptide — Retatrutide 20mg research peptide supplied for laboratory research purposes. Retatrutide is a synthetic triple agonist peptide targeting the GLP-1, GIP, and glucagon receptors simultaneously, manufactured to ≥99% purity and HPLC-verified for use in scientific research. Dispatched from the UK with a Certificate of Analysis available upon request.
For in-vitro and laboratory research use only. Not for human or animal consumption, personal use, or self-administration.
Kit Contents
- 1 × vial of Retatrutide 20mg (lyophilised)
- 1 × 3ml vial of bacteriostatic water
Retatrutide 20mg Research Information
Retatrutide (LY3437943) is an investigational peptide developed by Eli Lilly and Company. As a GLP-1 research peptide and triple incretin receptor agonist, it has been studied in preclinical and clinical research for its effects on metabolic pathways, energy homeostasis, and adipose tissue biology. The TRIUMPH-1 Phase 3 trial, with topline results published in May 2026, reported a mean body weight reduction of 28.3% at 80 weeks in participants receiving the highest dose, with 45.3% of participants achieving ≥30% weight reduction.
Areas of Scientific Interest
- Triple incretin receptor agonism (GLP-1, GIP, glucagon)
- Metabolic rate and energy expenditure research
- Adipose tissue biology and lipid metabolism
- Insulin sensitivity and glucose homeostasis models
- Comparative agonist pharmacology across incretin receptor subtypes
- Body weight regulation and energy balance research
Product Specifications
- Product: Retatrutide
- Quantity: 20mg
- Format: Lyophilised powder
- Purity: ≥99%
- Verification: HPLC-tested, Certificate of Analysis available
- Intended use: Research purposes only
- Storage: Store at −20°C, away from light and moisture
- Dispatched from the UK
Research Applications
Retatrutide 20mg is of significant interest across metabolic biology, endocrinology, and obesity research disciplines. Studies have investigated its role in triple incretin receptor agonism, adipose tissue remodelling, and glucose homeostasis. All applications are strictly for qualified laboratory research use.
Storage & Handling
Store lyophilised Retatrutide 20mg at −20°C, protected from light and moisture. Reconstitute with the supplied bacteriostatic water under sterile conditions immediately prior to use. Once reconstituted, store at 4°C and use within recommended timeframes.
Frequently Asked Questions
What is Retatrutide 20mg?
Retatrutide 20mg is a synthetic GLP-1, GIP, and glucagon triple agonist research peptide supplied strictly for in-vitro and laboratory research purposes.
Is Retatrutide 20mg available in the UK?
Yes. Retatrutide 20mg GLP-1 research peptide is dispatched from the UK with a Certificate of Analysis available upon request.
What purity is your Retatrutide 20mg?
All Retatrutide 20mg vials are manufactured to ≥99% purity and independently HPLC-verified.
Can I buy Retatrutide 20mg in the UK for research?
Retatrutide 20mg is available for qualified laboratory research applications. It is not intended for human or animal use.
For research use only. Not for human consumption, therapeutic use, or veterinary use.
Also available in higher-dose and pen formats: Retatrutide 40mg Vial, Retatrutide 30mg Peptide Pen, Retatrutide 40mg Peptide Pen. Related research peptides: MOTS-C 10mg, NAD+ 500mg. View our full research peptide range. Further reading: What is Retatrutide? GLP-1 Research Guide.